Charles Wykoff
Physician · Retina Consultants of America
Credentials: · · · · ·
History
- 2010–2011
Bascome Palmer Eye Institute
- 2005–2006
- 2001–2005
Research
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Nature · 1999 · 4,242 citations
Hypoxia-inducible expression of tumor-associated carbonic anhydrases
Cancer Research · 2000 · First of 13 authors · 1,129 citations
Diabetic Retinopathy: A Position Statement by the American Diabetes Association
Diabetes Care · 2017 · 679 citations
- DB
80 papers
52 papers
- DB
25 papers
- SG
23 papers
22 papers
22 papers
- AK
21 papers
- JH
21 papers
Clinical trials
- 2022–2032
Retina BioBank: Retina Biomarkers for a Deeper Understanding of Vitreoretinal and Systemic Diseases
Principal investigator · Enrolling by invitation
Greater Houston Retina Research
- 2022–2024
Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema
Principal investigator · Terminated
Greater Houston Retina Research
- 2016–2019
Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
Principal investigator · Completed · Phase 2
Charles C Wykoff, PhD, MD
- 2014–2017
Principal investigator · Completed · Phase 4
Greater Houston Retina Research